COMMUNIQUÉS West-GlobeNewswire

Melinta Therapeutics Launches Antibiotic Baxdela™ (delafloxacin) in the United States
29/01/2018
– Approved for adult patients with acute bacterial skin and skin structure infections (ABSSSI) – – Provides coverage of gram-positive and gram-negative pathogens; only FDA-approved fluoroquinolone for methicillin- [...]
Athersys CEO to Speak at the 2018 Brain Health Summit
29/01/2018
CLEVELAND, Ohio, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today that Gil Van Bokkelen, Chairman and CEO, will be a speaker and panelist at the 2018 Brain Health Summit organized by the [...]
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
29/01/2018
HIGHLIGHTS Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month Ohio State University: patient recruitment for the collaborative clinical research study [...]
SuperSonic Imagine to Present Aixplorer® Ultimate at the Arab Health Congress
29/01/2018
AIX-EN-PROVENCE, France, Jan. 29, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI) (FR0010526814, eligible savings plan in shares-SME), an ultrasound medical imaging company, presents Aixplorer ® Ultimate, [...]
Correction to company release dated January 26, 2018 - Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - number of shares
29/01/2018
FIT Biotech Oy Company release January 29, 2018 at 11:35 AM EET Correction to company release dated January 26, 2018 - Conversion of FIT Biotech Oy's Convertible Capital Notes into shares - number of shares Due to the [...]
Christoffer Lorenzen appointed member of the Executive Board of Chr. Hansen Holding A/S
29/01/2018
Company Announcement No. 4/2018 http://prlibrary-eu.nasdaq.com/Resource/Download/18843394-b4f7-4201-8d23-a23ed4168976
CORRECTION:Sanofi va acquérir Ablynx pour 3,9 milliards d'euros
29/01/2018
Il sagit dune correction du communiqué 08:19 29.01.2018 CET. Explication de la modification: Le nom d'Ablynx était mal orthographié dans le 11ème paragraphe. Communiqué de Presse Source: Sanofi (EURONEXT: SAN) (NYSE: [...]
Proposals of the Shareholders' Nomination Board of Terveystalo Plc to the Annual General Meeting 2018
29/01/2018
Terveystalo Plc Stock Exchange Release 29 January 2018 at 10:00 EET The Shareholders' Nomination Board of Terveystalo has submitted its proposal on the Board of Directors to the Annual General Meeting 2018. Proposal on [...]
Reminder Invitation webcast Year-end report 2017
29/01/2018
Press release 2018-01-29 Reminder: C-RAD Web Presentation Year-end Report 2017 Presentation of the report for the fiscal year 2017: Date: Thursday January 31, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD [...]
CellaVision AB presents the year-end bulletin for 2017 on February 9 at 11:00 CET
29/01/2018
The information was submitted to the public on January 29, 2018 at 8:20 CET CellaVision will publish the year-end bulletin for 2017 on February 9, 2018 at 08:20 CET. The report will be available at www.cellavision.com [...]
SANOFI TO ACQUIRE ABLYNX FOR €3.9 BILLION
29/01/2018
Regulated information - inside information Strengthens Sanofi's R&D strategy with innovative Nanobody ® technology platform Expands growing rare blood disorders franchise with Ablynx's late-stage investigational [...]
Sanofi to acquire Ablynx for €3.9 Billion
29/01/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to acquire Ablynx for €3.9 Billion Strengthens Sanofi's R&D strategy with innovative Nanobody ® technology platform Expands growing rare blood [...]
Sanofi va acquérir Ablynx pour 3,9 milliards d'euros
29/01/2018
Communiqué de Presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi va acquérir Ablynx pour 3,9 milliards d'euros Renforcement de la stratégie R&D de Sanofi avec une plateforme technologique innovante spécialisée [...]
Santhera Reports Preliminary Key Financial Figures for 2017 and Provides Corporate Update
29/01/2018
Liestal, Switzerland, January 29, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces preliminary, unaudited key financial figures for 2017. The Company reports an increase of 21% year-on-year in net revenues to CHF [...]
MediciNova Announces MN-001 (tipelukast) NASH/NAFLD Phase 2 Trial Interim Results Selected for Presentation at the International Liver Congress 2018 in Paris, France
29/01/2018
LA JOLLA, Calif., Jan. 28, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
VBI Vaccines Announces Changes to its Board of Directors
26/01/2018
Sam Chawla, of Perceptive Advisors, to resign from VBI Board of Directors Tomer Kariv, Chairman and CEO of The Pontifax Group, to replace Ran Nussbaum on VBI’s Board of Directors CAMBRIDGE, Mass., Jan. 26, 2018 (GLOBE [...]
TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
26/01/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 26, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix [...]
Repros Announces Negative Opinion From the EMA for Enclomiphene
26/01/2018
THE WOODLANDS, Texas, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® , (Nasdaq: RPRX ) ("Repros" or the "Company") today announced that, consistent with the previously disclosed guidance from the European [...]
IntelGenx Mourns the Passing of long term Director Ian Troup
26/01/2018
SAINT-LAURENT, Quebec, Jan. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (“IntelGenx”), (TSXV:IGX) (OTCQX:IGXT) -- The Board of Directors of IntelGenx was advised today of the passing of its long term [...]

Pages